High-Density Lipoprotein and Atherosclerosis: The Role of Antioxidant Activity

被引:0
|
作者
Salman Bandeali
John Farmer
机构
[1] Baylor College of Medicine,Department of Medicine
来源
Current Atherosclerosis Reports | 2012年 / 14卷
关键词
High density lipoprotein; Atherosclerosis; Reverse cholesterol transport; Antioxidant; Endothelial function;
D O I
暂无
中图分类号
学科分类号
摘要
Levels of high-density lipoprotein (HDL) cholesterol are generally inversely associated with the risk for the development of atherosclerosis. The mechanism by which HDL imparts protection from the initiation and progression of occlusive vascular disease is complex and multifactorial. The major anti-atherosclerotic effect of HDL is felt to be reverse cholesterol transport. HDL has been demonstrated to scavenge cholesterol from the peripheral vasculature with transport to the liver, where is it excreted in the biliary system. However, HDL exhibits multiple other physiologic effects that may play a role in the reduced risk for atherosclerosis. HDL has been demonstrated to exhibit beneficial effects on platelet function, endothelial function, coagulation parameters, inflammation, and interactions with triglyceride-rich lipoproteins. Increasing amounts of clinical and experimental data have shown that HDL cholesterol has significant antioxidant effect that may significantly contribute to protection from atherosclerosis.
引用
收藏
页码:101 / 107
页数:6
相关论文
共 50 条
  • [31] Utility of Atherosclerosis Imaging in the Evaluation of High-Density Lipoprotein-Raising Therapies
    Duivenvoorden, Raphael
    Fayad, Zahi A.
    CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (03) : 277 - 284
  • [32] High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis.
    Kawashiri M.A.
    Maugeais C.
    Rader D.J.
    Current Atherosclerosis Reports, 2000, 2 (5) : 363 - 372
  • [33] Desmocollin 1 is abundantly expressed in atherosclerosis and impairs high-density lipoprotein biogenesis
    Choi, Hong Y.
    Ruel, Isabelle
    Malina, Abba
    Garrod, David R.
    Oda, Michael N.
    Pelletier, Jerry
    Schwertani, Adel
    Genest, Jacques
    EUROPEAN HEART JOURNAL, 2018, 39 (14) : 1194 - +
  • [34] High-Density Lipoprotein and Atherosclerosis Regression Evidence From Preclinical and Clinical Studies
    Feig, Jonathan E.
    Hewing, Bernd
    Smith, Jonathan D.
    Hazen, Stanley L.
    Fisher, Edward A.
    CIRCULATION RESEARCH, 2014, 114 (01) : 205 - 213
  • [35] High-Density Lipoprotein Infusion Therapy and Atherosclerosis Current Research and Future Directions
    Chen, Nan
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2016, 24 (06) : 298 - 302
  • [36] High-density lipoprotein: A potent inhibitor of inflammation
    Murphy, Andrew J.
    Woollard, Kevin J.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (07) : 710 - 718
  • [37] A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis
    Hua, Susan
    Song, Changjie
    Geczy, Carolyn L.
    Ben Freedman, S.
    Witting, Paul K.
    REDOX REPORT, 2009, 14 (05) : 187 - 196
  • [38] The role of high-density lipoprotein cholesterol in atherothrombosis
    Choi, Brian G.
    Vilahur, Gemma
    Viles-Gonzalez, Juan F.
    Badimon, Juan J.
    MOUNT SINAI JOURNAL OF MEDICINE, 2006, 73 (04): : 690 - 701
  • [39] Preparation and Activity Analysis of Recombinant Human High-Density Lipoprotein
    Su, Manman
    Chang, Weiqin
    Shi, Kaiyao
    Wang, Dingding
    Wang, Mingxing
    Xu, Tianmin
    Yan, Weiqun
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2012, 10 (05) : 485 - 491
  • [40] High-density lipoprotein cholesterol and the role of statins
    Chong, PH
    Kezele, R
    Franklin, C
    CIRCULATION JOURNAL, 2002, 66 (11) : 1037 - 1044